View of NEXT-GENERATION DIAGNOSTICS IN ACUTE LYMPHOBLASTIC LEUKEMIA: FROM ULTRA-SENSITIVE MEASURABLE RESIDUAL DISEASE TO ARTIFICIAL INTELLIGENCE (2020–2026)

Return to Article Details NEXT-GENERATION DIAGNOSTICS IN ACUTE LYMPHOBLASTIC LEUKEMIA: FROM ULTRA-SENSITIVE MEASURABLE RESIDUAL DISEASE TO ARTIFICIAL INTELLIGENCE (2020–2026) Download Download PDF